The analysis of these datasets revealed a predominant expression of GRB7 in malignant cells as opposed to immune cells, a pattern consistent across not only ovarian cancers but also a broad spectrum of other cancer types (Figure 5). Here, GRB7 is linked to ovarian carcinoma.